Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe - 22/12/17
Doi : 10.1016/S1473-3099(17)30724-7
Mike Sharland a, Celine Pulcini c, b, Stephan Harbarth d, e, Mei Zeng f, Sumanth Gandra g, Shrey Mathur a, Nicola Magrini h 
on behalf of the
on behalf of the
21st WHO Expert Committee on Selection and Use of Essential Medicines
a Paediatric Infectious Diseases Research Group, Institute for Infection and Immunity, St George’s, University of London, London, UK
b Department of Infectious Diseases, Centre Hospitalier Régional Universitaire (CHRU) de Nancy, Nancy, France
c EA 4360 APEMAC, University of Lorraine, Nancy, France
d Infection Control Programme, University of Geneva Hospitals, Geneva, Switzerland
e Department of Internal Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
f Department of Infectious Diseases, Children’s Hospital of Fudan University, Shanghai, China
g Centre for Disease Dynamics, Economics & Policy, New Delhi, India
h Department of Essential Medicines and Health Products, World Health Organization, 1211 Geneva 27, Switzerland
Le texte complet de cet article est disponible en PDF.
© 2018
Elsevier Ltd. Tous droits réservés.
Vol 18 - N° 1
P. 18-20 - janvier 2018 Retour au numéro
Article précédent
- Learning about HIV the hard way: HIV among Chinese MSM attending university
- Huachun Zou, Joseph D Tucker, Song Fan, Junjie Xu, Maohe Yu, Zhenzhou Luo, Weiping Cai, Andrew E Grulich
- The cover artist for this year
- Marco De Ambrogi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?